TickerFacts.

Ceribell, Inc. (CBLL): Revenue

Annual figures by period end, from SEC filings.

$89.06M
Year ended 2025-12-31
$101.96M
Trailing 12 months to 2026-06-30
2023-12-31: $45.23M2024-12-31: $65.44M2025-12-31: $89.06M$89.06M
2023-12-31 Revenue (USD) 2025-12-31
Period endedRevenueChange YoYSource filing
2025-12-31$89.06M+36.1%2026-02-24, From 2025-01-01
2024-12-31$65.44M+44.7%2026-02-24, From 2024-01-01
2023-12-31$45.23Mn/a2025-02-25, From 2023-01-01

Revenue at similar companies

Companies with the same SEC industry code (Electromedical & Electrotherapeutic Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedRevenueChange YoY
Ceribell, Inc. (CBLL)2025-12-31$89.06M+36.1%
Vaso Corp (VASO)2025-12-31$89.10M+2.7%
Biolife Solutions Inc (BLFS)2025-12-31$96.21M+28.9%
Electromed, Inc. (ELMD)2026-06-30$73.78M+15.3%
Outset Medical, Inc. (OM)2025-12-31$119.48M+5.1%
Iridex Corp (IRIX)2026-01-03$52.67M+8.2%
Axogen, Inc. (AXGN)2025-12-31$225.21M+20.2%
Stereotaxis, Inc. (STXS)2025-12-31$32.38M+20.3%
electroCore, Inc. (ECOR)2025-12-31$32.03M+27.2%

Compare CBLL, VASO, BLFS, ELMD side by side · Screen every company in Electromedical & Electrotherapeutic Apparatus ↗